Home > Insider Trading > Filing (0001493152-21-000247)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
318306	Abeona Therapeutics Inc.	ABEO	Pharmaceutical Preparations (2834)	830221517

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1744816	Elliot Paul Mann	1330 Avenue Of The Americas, 33Rd Floor New York NY 10019		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2020-12-31	609,755	$0.00	163,152	No	4	D	Direct
Common Stock	Disposition	2021-01-04	30,488	$1.54	132,664	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	D	Direct
No	4	S	Direct

Footnotes

Represents unvested shares of restricted common stock granted to the reporting person on October 8, 2020 in connection with the formation of a special committee of the Issuer's board of directors as reported on Form 8-K on October 6, 2020. These shares were scheduled to vest in monthly installments only while the special committee was operational and the reporting person was providing service to the special committee; the special committee was dissolved on December 31, 2020. The reporting person continues to serve on the Issuer's board of directors.
The sales reported in this Form 4 were to cover tax obligations associated with vested restricted stock awards and were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 19, 2020.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.50 to $1.58, inclusive. The reporting person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote.